Monoclonal Antibody to Bone Marrow Stromal Cell Antigen 2 Protein of Swine.

Ning Kong,Qiong Meng,Yongguang Wu,Zhongze Wang,Yewen Zuo,Wu Tong,Hao Zheng,Guoxin Li,Shen Yang,Hai Yu,Tongling Shan,En-Min Zhou,Guangzhi Tong
DOI: https://doi.org/10.1089/mab.2016.0007
2016-01-01
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Abstract:The bone marrow stromal cell antigen 2 (BST-2) protein was identified as a novel virus restriction factor that potently restricts the replication and egress of enveloped viruses. In this study, we generated monoclonal antibodies (MAbs) against porcine BST-2 encoding 34-112 aa of porcine BST-2, which was cloned and inserted into the prokaryotic expression vector pCold-I to construct a recombinant plasmid pCold-pBST-2. The recombinant porcine BST-2 protein (rpBST-2 protein) was induced by isopropyl-β-D-thiogalactoside in Escherichia coli BL21 (DE3). Then, BALB/c mice were immunized with the purified rpBST-2 protein to prepare MAbs of BST-2. After subcloning, one strain of hybridoma cells named 1B2 secreting porcine BST-2 protein monoclonal antibody (MAb) was obtained. Indirect immunofluorescence assay and western blot analysis showed that the MAb was specifically reacted with the overexpressed porcine BST-2 protein in Vero cells. The specific MAb of porcine BST-2 provides a valuable tool for further studies of BST-2 to restrict virus infection.
What problem does this paper attempt to address?